GKOS
Price
$82.76
Change
-$4.71 (-5.38%)
Updated
Sep 12 closing price
Capitalization
4.75B
44 days until earnings call
PEN
Price
$272.73
Change
-$3.67 (-1.33%)
Updated
Sep 12 closing price
Capitalization
10.64B
44 days until earnings call
Interact to see
Advertisement

GKOS vs PEN

Header iconGKOS vs PEN Comparison
Open Charts GKOS vs PENBanner chart's image
Glaukos
Price$82.76
Change-$4.71 (-5.38%)
Volume$883.62K
Capitalization4.75B
Penumbra
Price$272.73
Change-$3.67 (-1.33%)
Volume$454.55K
Capitalization10.64B
GKOS vs PEN Comparison Chart in %
Loading...
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GKOS vs. PEN commentary
Sep 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GKOS is a StrongBuy and PEN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 15, 2025
Stock price -- (GKOS: $82.76 vs. PEN: $272.73)
Brand notoriety: GKOS and PEN are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: GKOS: 93% vs. PEN: 96%
Market capitalization -- GKOS: $4.75B vs. PEN: $10.64B
GKOS [@Medical/Nursing Services] is valued at $4.75B. PEN’s [@Medical/Nursing Services] market capitalization is $10.64B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $232.75B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GKOS’s FA Score shows that 0 FA rating(s) are green whilePEN’s FA Score has 0 green FA rating(s).

  • GKOS’s FA Score: 0 green, 5 red.
  • PEN’s FA Score: 0 green, 5 red.
According to our system of comparison, PEN is a better buy in the long-term than GKOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GKOS’s TA Score shows that 5 TA indicator(s) are bullish while PEN’s TA Score has 4 bullish TA indicator(s).

  • GKOS’s TA Score: 5 bullish, 4 bearish.
  • PEN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both GKOS and PEN are a good buy in the short-term.

Price Growth

GKOS (@Medical/Nursing Services) experienced а -11.90% price change this week, while PEN (@Medical/Nursing Services) price change was -3.10% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.34%. For the same industry, the average monthly price growth was +3.98%, and the average quarterly price growth was +29.53%.

Reported Earning Dates

GKOS is expected to report earnings on Oct 29, 2025.

PEN is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Medical/Nursing Services (+2.34% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PEN($10.6B) has a higher market cap than GKOS($4.75B). PEN YTD gains are higher at: 14.843 vs. GKOS (-44.805). PEN has higher annual earnings (EBITDA): 194M vs. GKOS (-47.8M). PEN has more cash in the bank: 425M vs. GKOS (275M). GKOS has less debt than PEN: GKOS (105M) vs PEN (221M). PEN has higher revenues than GKOS: PEN (1.28B) vs GKOS (433M).
GKOSPENGKOS / PEN
Capitalization4.75B10.6B45%
EBITDA-47.8M194M-25%
Gain YTD-44.80514.843-302%
P/E RatioN/A72.15-
Revenue433M1.28B34%
Total Cash275M425M65%
Total Debt105M221M48%
FUNDAMENTALS RATINGS
GKOS vs PEN: Fundamental Ratings
GKOS
PEN
OUTLOOK RATING
1..100
5741
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
81
Overvalued
PROFIT vs RISK RATING
1..100
6483
SMR RATING
1..100
9563
PRICE GROWTH RATING
1..100
8649
P/E GROWTH RATING
1..100
59100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PEN's Valuation (81) in the Medical Specialties industry is in the same range as GKOS (95). This means that PEN’s stock grew similarly to GKOS’s over the last 12 months.

GKOS's Profit vs Risk Rating (64) in the Medical Specialties industry is in the same range as PEN (83). This means that GKOS’s stock grew similarly to PEN’s over the last 12 months.

PEN's SMR Rating (63) in the Medical Specialties industry is in the same range as GKOS (95). This means that PEN’s stock grew similarly to GKOS’s over the last 12 months.

PEN's Price Growth Rating (49) in the Medical Specialties industry is somewhat better than the same rating for GKOS (86). This means that PEN’s stock grew somewhat faster than GKOS’s over the last 12 months.

GKOS's P/E Growth Rating (59) in the Medical Specialties industry is somewhat better than the same rating for PEN (100). This means that GKOS’s stock grew somewhat faster than PEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GKOSPEN
RSI
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
69%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 3 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 3 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
71%
Bullish Trend 3 days ago
74%
Advances
ODDS (%)
Bullish Trend 18 days ago
78%
Bullish Trend 6 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
68%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
78%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FOCT47.000.03
+0.05%
FT Vest US Equity Buffer ETF Oct
AUDNZD1.12N/A
N/A
Australian Dollar - New Zealand Dollar
CNYCAD0.19N/A
N/A
China Yuan - Canadian Dollar
GBPCAD1.88N/A
N/A
United Kingdom Pound - Canadian Dollar
UTEN44.46-0.13
-0.29%
F/m US Treasury 10 Year Note ETF

GKOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with ISRG. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GKOS
1D Price
Change %
GKOS100%
-5.38%
ISRG - GKOS
51%
Loosely correlated
-1.35%
NTRA - GKOS
48%
Loosely correlated
-3.05%
RDNT - GKOS
48%
Loosely correlated
+0.38%
ITGR - GKOS
48%
Loosely correlated
-2.77%
DXCM - GKOS
46%
Loosely correlated
+0.29%
More